Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase

Molecular Immunology

Volumn 44, Issue 6, 2007, Pages 1105-1114

  Rawal, Nenoo ^a   Pangburn, Michael K ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Additional C3b molecules; C3 convertase; C4b binding protein; C5 convertase; Complement classical pathway; Regulation

Indexed keywords

BINDING PROTEIN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B;

ANIMAL CELL; ARTICLE; BINDING SITE; BLOOD ANALYSIS; BLOOD LEVEL; CELL DENSITY; CELL SURFACE; COMPLEX FORMATION; DISSOCIATION CONSTANT; ENZYME SPECIFICITY; IC 50; LIQUID; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; BINDING SITES; CHICKENS; COMPLEMENT C3B; COMPLEMENT C4B-BINDING PROTEIN; COMPLEMENT C5 CONVERTASE, CLASSICAL PATHWAY; HUMANS; PROTEIN BINDING;

EID: 33748769533     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.07.282     Document Type: Article

References (37)

1. Barilla-laBarca M.L., Liszewski M.K., Lambris J.D., Hourcade D., and Atkinson J.P. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells. J. Immunol. 168 (2002) 6298-6304
2. Blom A.M., Kask L., and Dahlbäck B. CCP1-4 of the C4b-binding protein α-chain are required for factor I mediated cleavage of complement factor C3b. Mol. Immunol. 39 (2003) 547-556
3. Blom A.M., Kask L., and Dahlbäck B. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276 (2001) 27136-27144
4. Blom A.M., Webb J., Villoutreix B.O., and Dahlbäck B. A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 274 (1999) 19237-19245
5. Blom A.M., Zadura A.F., Villoutreix B.O., and Dahlbäck B. Positively charged amino acids at the interface between α-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. Mol. Immunol. 37 (2000) 445-453
6. Christopherson R.I. Desalting protein solutions in a centrifuge column. Meth. Enzymol. 91 (1983) 278-281
7. Discipio R.G. The conversion of human complement component C5 into fragment C5b by the alternative pathway C5 convertase. Biochem. J. 199 (1981) 497-504
8. Dodds A.W. Small-scale purification of complement components. In: Colowick S.P., and Kaplan N.O. (Eds). Methods in Enzymology (1993), Academic Press, Inc., San Diego 46-60
9. Esser A.F., and Sodetz J.M. Membrane attack complex proteins C5b-6, C7, C8, and C9 of human complement. Meth. Enzymol. 162 (1998) 551-578
10. Fujita T., and Nussenzweig V. The role of C4-binding protein and β1H in proteolysis of C4b and C3b. J. Exp. Med. 150 (1979) 267-276
11. Fujita T., and Tamura N. Interaction of C4-binding protein with cell-bound C4b: a quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b. J. Exp. Med. 157 (1983) 1239-1251
12. Fukui A., Yuasa-Nakagawa T., Murakami Y., Funami K., Kishi N., Matsuda T., Fujita T., Seya T., and Nagasawa S. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis. J. Biochem. 132 (2002) 719-728
13. Gigli I., Fujita T., and Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 6596-6600
14. Gigli I., Sorvillo J., and Halbwachs-Mecarelli L. Regulation and deregulation of the fluid-phase classical pathway C3 convertase. J. Immunol. 135 (1985) 440-444
15. Hammer C.H., Wirtz G.H., Renfer L., Gresham H.D., and Tack B.F. Large scale isolation of functionally active components of the human complement system. J. Biol. Chem. 256 (1981) 3995-4006
16. Kerr M.A., and Porter R.R. The purification and properties of the second component of human complement. Biochem. J. 171 (1978) 99-107
17. Kolb W.P., Kolb L.M., and Savar J.R. Biochemical characterization of the sixth component (C6) of human complement. Biochemistry 21 (1982) 294-301
18. Krych-Goldberg M., Hauhart R.E., Porzukowiak T., and Atkinson J.P. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors. J. Immunol. 175 (2005) 4528-4535
19. Liszewski M.K., Farries T.C., Lublin D.M., Rooney I.A., and Atkinson J.P. Control of the complement system. Adv. Immunol. 61 (1996) 201-283
20. Medof N., and Nussenzweig V. Control of the function of substrate-bound C4b-C3b by the complement receptor CR1. J. Exp. Med. 159 (1984) 1669-1685
21. In: Morgan B.P., and Harris C. (Eds). Complement Regulatory Proteins (1999), Academia, San Diego
22. Nagasawa S., and Stroud R.M. Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b′). Immunochemistry 14 (1977) 749-756
23. Pangburn M.K., and Müller-Eberhard H.J. Complement C3 convertase: cell surface restriction of βIH control and generation of restriction on neuraminidase treated-cells. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 2416-2420
24. Pangburn M.K., and Müller-Eberhard H.J. Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I. Biochemistry 22 (1983) 178-185
25. Pangburn M.K. A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement. J. Immunol. Meth. 102 (1987) 7-14
26. Parker C.J. Membrane Defenses Against Attack by Complement and Performs (1992), Springer, Berlin
27. Perkins S.J., Chung L.P., and Reid K.B.M. Unusual ultrastructure of complement-component-C4b-binding protein of human complement by synchroton X-ray scattering and hydrodynamic analysis. Biochem. J. 233 (1986) 799-807
28. Rawal N., and Pangburn M.K. Formation of high affinity C5 convertases of the alternative pathway of complement. J. Immunol. 166 (2001) 2635-2642
29. Rawal N., and Pangburn M.K. Formation of high-affinity C5 convertase of the classical pathway of complement. J. Biol. Chem. 278 (2003) 38476-38483
30. Rawal N., and Pangburn M.K. C5 convertase of the alternative pathway of complement. Kinetic analysis of the free and surface-bound forms of the enzyme. J. Biol. Chem. 273 (1998) 16828-16835
31. Reilly B.D., Makrides S.C., Ford P.J., Marsh H.C., and Mold C. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1). J. Biol. Chem. 269 (1994) 7696-7701
32. Rother K. Complement in inflammation. In: Rother K., Till G.O., and Hänsch G.M. (Eds). The Complement System (1998), Springer, New York 462-471
33. Tacnet-Delorme P., Boyer V., Thielens N.M., Hernandez J.-F., Bally I., Sim R.B., Desgranges C., and Arlaud G.J. In vitro analysis of complement-dependent HIV-1 cell infection using a model system. J. Immunol. 162 (1999) 4088-4093
34. Takata Y., Kinoshita T., Kozono H., Takeda J., Tanaka E., Hong K., and Inoue K. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway. J. Exp. Med. 165 (1987) 1494-1507
35. Trouw L.A., Nilsson S.C., Goncalves I., Landberg G., and Blom A.M. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Emerg. Med. 201 (2005) 1937-1948
36. Volanakis J.E. Overview of the complement system. In: Volanakis J.E., and Frank M.M. (Eds). The Human Complement System in Health and Disease (1998), Marcel Dekker, Inc., New York 9-32
37. Ziccardi R.J., Dahlbäck B., and Müller-Eberhard H.J. Charactrization of the interaction of human C4b-binding protein with physiological ligands. J. Biol. Chem. 259 (1984) 13674-13679